These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 19765428

  • 1. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H, Qorashi M, Heidari A.
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
    Lazda VA.
    Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
    [Abstract] [Full Text] [Related]

  • 3. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W.
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [Abstract] [Full Text] [Related]

  • 4. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
    Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovitch N, Huerta-Hartal M, Ankol OE.
    Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994
    [Abstract] [Full Text] [Related]

  • 5. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K.
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G, Daniel V, Naujokat C, Döhler B.
    Transplantation; 2009 Oct 27; 88(8):962-7. PubMed ID: 19855238
    [Abstract] [Full Text] [Related]

  • 7. [CMC and EBV infections in children].
    Polz-Dacewicz M, Stec A, Koncewicz R.
    Przegl Epidemiol; 2002 Oct 27; 56(1):65-72. PubMed ID: 12150069
    [Abstract] [Full Text] [Related]

  • 8. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 27; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 9. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.
    Sepehrvand N, Khameneh ZR, Eslamloo HR.
    Saudi J Kidney Dis Transpl; 2010 Mar 27; 21(2):363-7. PubMed ID: 20228534
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
    Zadeh ZR, Makhdumi K, Lak SS.
    Saudi J Kidney Dis Transpl; 2006 Sep 27; 17(3):351-4. PubMed ID: 16970255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 27; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 16. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
    Geramizadeh B, Aghdai M, Azarpira N, Behabahani AB, Heidari T, Banihashemi M, Raisjalali AR, Roozbeh J, Behzadi A.
    Transplant Proc; 2005 Sep 27; 37(7):3051-2. PubMed ID: 16213301
    [Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
    Varga M, Görög D, Kári D, Környei E, Kis É, Túryné HJ, Jankovics I, Péter A, Toronyi É, Sárváry E, Fazakas J, Reusz G.
    Transplant Proc; 2011 May 27; 43(4):1233-5. PubMed ID: 21620098
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y, Ito Y, Kaneko K, Shibata-Watanabe Y, Tainaka T, Sumida W, Nakamura T, Kamei H, Kiuchi T, Ando H, Kimura H.
    Transplant Proc; 2008 Dec 27; 40(10):3578-82. PubMed ID: 19100443
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years.
    Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A.
    J Clin Virol; 2006 Oct 27; 37(2):118-23. PubMed ID: 16971177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.